SEC Form 4 · accession 0000899243-16-023623
ROCKET PHARMACEUTICALS, INC. · RCKT
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Paul G Howes
Director
Period of report
Jun 23, 2016
Accepted (ET)
Jun 27, 2016 · 4:05 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001281895
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Options (Right to Buy)F2,F1 | $7.61 | Jun 23, 2016 | A | 12,000 | A | — | Jun 22, 2026 | Common Stock | 12,000 | 12,000 | D |
Explanation of responses
- F1The stock option award was issued pursuant to Inotek Pharmaceuticals Corporation's 2014 Stock Option and Incentive Plan. The option grant shall vest in equal quarterly installments at the end of each quarter following June 23, 2016, subject to continued service through such dates.
- F2As previously reported on June 26, 2015, Reporting Person was granted a stock option award under the Plan. The total beneficially owned derivative securities following the grant inadvertently included securities of a separate class, and, accordingly, such previously reported shares are now properly excluded.